# Beijing Gene Key Life Technology

Source: https://onco.cc/companies/beijing-gene-key-life-technology/  
OnCo record `beijing-gene-key-life-technology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Beijing Gene Key Life Technology is a Chinese developer in Beijing that sponsors 2 registered cancer trials of GKL-006.

## Summary

Beijing Gene Key Life Technology appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 1/2, 2), testing GKL-006 in hepatocellular carcinoma (hcc), unresectable hepatocellular cancer, advanced pancreatic cancer, ductal adenocarcinoma of pancreas. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Beijing Gene Key Life Technology Co., Ltd
- Tags: ctgov-sponsor; china; registry-only
- HQ: Beijing, China
- Type: biotech

## Sources

- ClinicalTrials.gov: trials sponsored by Beijing Gene Key Life Technology: https://clinicaltrials.gov/search?spons=Beijing%20Gene%20Key%20Life%20Technology

## Connected records

- trials: [A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer](https://onco.cc/trials/nct07777211/), [GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma](https://onco.cc/trials/nct07209813/)

---
JSON: https://onco.cc/api/v1/entities/beijing-gene-key-life-technology.json